[HTML] mdpi.com

[HTML][HTML] Discovery, development, and patent trends on molnupiravir: a prospective oral treatment for COVID-19

M Imran, M Kumar Arora, SMB Asdaq, SA Khan… - Molecules, 2021 - mdpi.com
The COVID-19 pandemic needs no introduction at present. Only a few treatments are
available for this disease, including remdesivir and favipiravir. Accordingly, the …
被引用次数：189 相关文章
[HTML] nih.gov

[HTML][HTML] Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19

M Imran, MK Arora, SMB Asdaq, SA Khan, SI Alaqel… - Molecules, 2021 - ncbi.nlm.nih.gov
The COVID-19 pandemic needs no introduction at present. Only a few treatments are
available for this disease, including remdesivir and favipiravir. Accordingly, the …

Discovery, development, and patent trends on molnupiravir: a prospective oral treatment for COVID-19.

M Imran, MK Arora, SMB Asdaq, SA Khan, SI Alaqel… - 2021 - cabidigitallibrary.org
The COVID-19 pandemic needs no introduction at present. Only a few treatments are
available for this disease, including remdesivir and favipiravir. Accordingly, the …
[PDF] semanticscholar.org

[PDF][PDF] Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19

M Imran, M Kumar Arora, SMB Asdaq, SA Khan… - … - pdfs.semanticscholar.org
The COVID-19 pandemic needs no introduction at present. Only a few treatments are
available for this disease, including remdesivir and favipiravir. Accordingly, the …

Discovery, development, and patent trends on molnupiravir: A prospective oral treatment for covid-19

M Imran, MK Arora, SMB Asdaq, SA Khan, SI Alaqel… - …, 2021 - ksascholar.dri.sa
The COVID-19 pandemic needs no introduction at present. Only a few treatments are
available for this disease, including remdesivir and favipiravir. Accordingly, the …

Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19.

M Imran, M Kumar Arora, SMB Asdaq, SA Khan… - …, 2021 - search.ebscohost.com
The COVID-19 pandemic needs no introduction at present. Only a few treatments are
available for this disease, including remdesivir and favipiravir. Accordingly, the …

Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19

M Imran, MK Arora, SMB Asdaq, SA Khan, SI Alaqel… - Molecules, 2021 - cir.nii.ac.jp
抄録< jats: p> The COVID-19 pandemic needs no introduction at present. Only a few
treatments are available for this disease, including remdesivir and favipiravir. Accordingly …

Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19.

M Imran, SMB Asdaq, SA Khan, SI Alaqel… - Molecules (Basel …, 2021 - europepmc.org
The COVID-19 pandemic needs no introduction at present. Only a few treatments are
available for this disease, including remdesivir and favipiravir. Accordingly, the …

Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19

M Imran, MK Arora, SMB Asdaq… - Molecules (Basel …, 2021 - pubmed.ncbi.nlm.nih.gov
The COVID-19 pandemic needs no introduction at present. Only a few treatments are
available for this disease, including remdesivir and favipiravir. Accordingly, the …
[PDF] academia.edu

[PDF][PDF] Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19

M Imran, M Kumar Arora, SMB Asdaq, SA Khan… - Molecules - academia.edu
The COVID-19 pandemic needs no introduction at present. Only a few treatments are
available for this disease, including remdesivir and favipiravir. Accordingly, the …